# Public Workshop on Safety Assessment for Investigational New Drug Safety Reporting; Correction
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice; correction.
**SUMMARY:**
The Food and Drug Administration is correcting a notice entitled “Safety Assessment for Investigational New Drug Safety Reporting; Public Workshop” that appeared in the *Federal Register* of November 27, 2017. The document announced a public workshop to engage external stakeholders in discussions related to finalizing the draft guidance entitled “Safety Assessment for IND Safety Reporting.” The date of the meeting has changed.
**FOR FURTHER INFORMATION CONTACT:**
Lauren Wedlake, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 6362, Silver Spring, MD 20993, 301-796-2728, *[email protected].*
In the *Federal Register* of Monday, November 27, 2017, in FR Doc. 2017-25454, the following correction is made:
1. On page 56036, in the first column, in the first sentence of the *DATES* section, “The public workshop will be held on January 11, 2018, from 9 a.m. to 4 p.m., Eastern Time.” is corrected to read “The public workshop will be held on March 8, 2018, from 9 a.m. to 4 p.m., Eastern Time.”
Dated: December 8, 2017.
Leslie Kux,
Associate Commissioner for Policy.